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At least four different assays have been used to investigate the fine specificity 
of lymphocytes considered to possess T-cell characteristics. These methods in- 
clude delayed hypersensitivity reactions in guinea pigs (1-4),  in vitro prolifera- 
tion of peritoneal lymphocytes in guinea pigs (3, 4) and mice (5), macrophage 
migration  inhibition by  lymphocytes (4), and  the  generation  of cytotoxic T 
lymphocytes to viral-infected (6-9)  or chemically modified (10, 11) autologous 
cells. In the latter system, two basic models for the cytotoxic T-cell receptor have 
been proposed (12, 13): one involving a single receptor by which the lymphocyte 
recognizes the infectious or modifying agent and self-H-2 products as a single 
antigenic unit; and the other, in which the T lymphocyte expresses two distinct 
receptors,  one for ~'hapten" and the second for autologous H-2  products.  By 
challenging T lymphocytes from guinea pigs immunized with hapten coupled to 
mycobacteria with a  series of related haptens and carriers, Janeway and co- 
workers found that T  cells recognized neither hapten nor carrier  alone, but 
specificities involving both moieties (3, 4). An earlier report demonstrated that 
there was no detectable cross-reactivity within the same mouse strain between 
cytotoxic lymphocytes generated by sensitization with autologous cells modified 
with either trinitrobenzene sulfonate (TNBS)  or N-(3-nitro-4-hydroxy-5-iodo- 
phenylacetyl)-f~-alanylglycylglycyl (NIP-AGG)  acyl  azide  (11). The  present 
study further defines the fine specificity of cell-mediated lympholysis (CML) 
reactions against chemically modified autologous cells by comparing the speci- 
ficity of effector cells generated by sensitization with autologous lymphocytes 
from C57BL/10 mice modified with the acyl azides of NIP-AGG, NP-AGG, NIP, 
TNP-AGG,  and  with  TNBS  (see  Materials  and  Methods for  explanation of 
abbreviations). 
Materials and Methods 
Mice.  All mice used in these experiments were 7- to 9-wk-old C57BL/10  males obtained from 
The Jackson Laboratory, Bar Harbor, Maine. 
Tumor  Cells.  The  only tumor used in these experiments was L5MF-22  (H-2b),  a  radiation- 
induced lymphoma which arose in  a  B10.129(5M)  female mouse  (obtained from Dr.  Gustavo 
Cudkowicz, Department of Pathology, State University of New York,  Buffalo, N.  Y.) and was 
passed at 7- to 9-day intervals as ascitic fluid in C57BL/6  mice. 
Chemical Modifications of Spleen and Tumor Cells.  TNP modification of cells was performed 
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as  previously described (i0)  using  a I0  mM  TNBS solution  (Pierce  Chemical Co.,  Rockford, Ill.)  in 
phosphate-buffered saline,  pH 7.4. 
All  other compounds were  covalently  bound to  cells  using  haptens  in  the  form of  an acyl  azide  as 
previously  described for  NIP-AGG (  11, 14,  15).  These compounds included:  N-  (3-nitro-4-hydroxy-5- 
iodophenylacetyl)-B-alanylglycylglycyl (NIP-AGG)  azide; N-(3-nitro-4-hydroxyphenylacetyl)-fl- 
alanylglycylglycyl  (NP-AGG) azide;  N-(3-nitro-4-hydroxy-5-iodophenylacetyl)  (NIP) azide;  and  N- 
(2,4,6-trinitrophenyl)-fl-alanyglycylglycyl  (TNP-AGG) azide. 
In Vitro Cell  Culture and Assay for Cytotoxic Cells.  Splenic lymphocytes were sensitized  in 
vitro with chemically  modified spleen cells  in supplemented RPMI  1640 media as previously 
described (11).  After a 5 day incubation the cells  were harvested and their  cytotoxic activity 
measured as previously described (10).  Nonspecific lysis  of  modified target cells  was determined 
from the amount of  ~ICr  released from the appropriate 51Cr-labeled  target  cells,  incubated for  4 h 
with  effector  cells  which had been incubated 5 days with no  stimulators,  divided by the  maximum 
5~Cr  released by targets  that had been frozen,  and thawed repeatedly. 
Results 
Spleen  cells  from  C57BL/10 mice  were  sensitized  in  vitro  with  autologous 
spleen  cells  modified  with  TNBS  or  with  the  acyl  azide  of TNP-AGG.  The 
effector cells generated 5 days later were assayed on 5~Cr-labeled L5MF-22 (H- 
2 ~ lymphoma target cells modifed with either TNBS or TNP-AGG acyl azide. 
The results of five independent experiments (Table I) indicate that effector cells 
sensitized  with  autologous  TNP-modified cells  which  consistently  lysed H-2- 
matched,  TNP-modified targets never lysed H-2-matched, TNP-AGG-modified 
target cells. It was demonstrated in four of the five experiments that TNP-AGG- 
modified  targets  were  capable  of being  lysed,  since  effectors  generated  by 
sensitization  with  TNP-AGG-modified  autologous  cells  lysed  H-2-matched, 
TNP-AGG-modified target  cells.  A  variable degree of lysis was obtained from 
experiment  to  experiment  when  these  same  effectors  were  tested  on  H-2- 
matched, TNP-modified targets. This degree of lysis ranged from 75 (exp. 5-387) 
to 6% (experiment 5-439) of the lysis obtained on TNP-AGG-modified targets. It 
is noteworthy that  sensitization  against  autologous cells modified with TNP- 
AGG acyl azide was always weaker than with cells modified with TNBS. 
In another series of experiments the specificity of C57BL/10 cytotoxic effector 
cells was investigated as a function of sensitization with autologous spleen cells 
modified with the acyl .azides of NIP-AGG, NP-AGG, or NIP. The results of four 
independent experiments are summarized in Table II. In all cases effector cells 
sensitized with autologous NIP-AGG-modified spleen cells lysed H-2-matched, 
NIP-AGG-modified tumor targets to a greater extent than tumor targets modi- 
fied with the closely related acyl azides of NP-AGG or NIP. Tumor target cells 
modified  with  TNP-AGG  were not  lysed to  any  appreciable  extent  by these 
effectors. 
NP-AGG-modified  autologous  cells  were  only  marginally  immunogenic  as 
sensitizing  cells  since  weak responses  were detected in  only two out  of four 
experiments. In experiments 5-451 and 5-413, in which sensitization to NP-AGG- 
modified cells was obtained,  variable cross-reactivity was observed with NIP- 
AGG-modified targets, and no cross-reactivity was obtained with NIP-modified 
targets. 
Sensitization  of C57BL/10  spleen  cells  with  NIP-modified  autologous  cells 
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TABLE  I 
In Vitro Induction of Cytotoxicity of C57BL/IO Spleen Cells by TNP-Modified or TNP- 
A GG-Modified Spleen Cells to TNP-Modified and TNP-A GG-Modified L5MF-22 Tumor 
Target Cells 
Stimulating 
C57BL/10 spleen  L5MF-22 target 
cells  modified  cells  modified 
with:  with: 
% Specific lysis + SE in  exp.  no.: 
5-387*  5-407*  5-412"  5-419"  5-439* 
TNP  TNP  45.2  ±  1.7  30.3  ±  2.2  45.6  ±  2.1  27.6 -+  2.0  39.6 ±  2.9 
TNP  TNP-AGG  6.4 .+  2.3  1.6 ±  2.5  NT*  (-4.0  ±  3.2)  2.0 ±  2.9 
TNP-AGG  TNP-AGG  11.5  +-  2.7  25.6  ±  4.6  22.2  +-  2.3  NT  13.0 ±  2.3 
TNP-AGG  TNP  8.6 .+  1.7  NT  11.9 +-  2.0  NT  0.8 ±  0.4 
* Experiment  number,  effector:target  ratio: 5-387, 80:1; 5-407, 20:1; 5-412, 40:1; 5-4t9, 40:i; and 5-439, 160:1. 
$ NT, not tested. 
TABLE  II 
In Vitro Induction of Cytotoxicity of C57BLH O Spleen Cells by NIP-A GG-, NP-A GG-, or 
NIP-Modified Spleen Cells to NIP-A GG-, NP-A GG-, or NIP-Modified L5MF-22 Tumor 
Target Cells 
Stimulating C57BL/10  LbMF-22 target cells 
spleen ceils  modified  modified with: 
with: 
% Specific lysis .+  SE in exp. no.: 
5-413"  5-419"  5-439*  5-451" 
NIP-AGG  NIP-AGG  54,1  ±  2.1  37.0 ±  1,6  24.8 -+  3.3  43.6 +-  1.3 
NIP-AGG  NP-AGG  22.3 ±  2.5  ]7.5  -+  2,1  2.0 ±  1.2  13.9 ±  1.3 
NIP-AGG  NIP  4.1  ±  2.6  10.7 .+  2.9  6.3 -+  3.4  10.1  .+ 2.3 
NIP-AGG  TNP-AGG  NT$  1.6 ±  3.6  2.9 +  1.4  5.3  ±  2.1 
NP-AGG  NIP-AGG  6.1 ±  1.3  (-13.8  ±  1.9)  (-7.6  -+  0.9)  11.1  .+  1.7 
NP-AGG  NP-AGG  11.1  ±  2.4  (-11,3  +-  1.8)  (-4.7  .+  1.6)  12.6 ±  1.2 
NP-AGG  NIP  O.0  ±  4.1  (-1.9 .+  3.5)  (-5.2  .+  1.6)  0.7 .+  1.8 
NIP  NIP-AGG  11,9 -+  2.0  (-6.0  .+  1.9)  2.7  ±  1.3  8.1  ±  1.1 
NIP  NP-AGG  3.6 .+ 2.0  (-1.4  .+  1.4)  0.3  ±  1.1  5.6 -+  0.5 
NIP  NIP  1O.1  ±  1.2  18.7  .+ 2.5  28.8 -+  3.7  20.2  +-  1.9 
* Experiment  number,  effector target ratio: 5-413, 80:1; 5-419, 160:1; 5-439, 80:1; and 5-451, 160:1. 
NT, not tested. 
No lysis by these effectors was detected on NP-AGG-modified targets in any of 
the experiments.  These effectors clearly lysed NIP-AGG-modified targets only 
in experiment 5-413. 
In order to further characterize  the specificity  of the cytotoxic lymphocytes, 
cold target inhibition experiments were performed in which nonradioactive cells 
modified with these reagents were used to block the effector phase of the CML 
(Table III).  Effector lymphocytes were generated  by sensitization  of C57BL/10 
spleen cells with either TNP-modified (section A) or NIP-AGG-modified (section 
B) autologous spleen cells,  and assayed on 51Cr-labeled, H-2-matched,  L5MF-22 
target  cells  modified  with  TNBS  or  NIP-AGG  acyl  azide,  respectively.  The 
results  shown in  section  A  demonstrate  that  only TNP-modified  spleen  cells 
were effective inhibitors of the cytotoxic reaction. In contrast, TNP-AGG-modi- 
fled spleen cells were no more effective in blocking cytolysis than were unmodi- 
fied C57BL/10 spleen cells. The lysis by effector cells generated by sensitization 
of C57BL/10 splenic lymphocytes with NIP-AGG-modified autologous-stimulat- 
ing cells was inhibited by NIP-AGG-modified spleen cells,  but not by unmodi- 
fied,  NP-AGG-modified,  nor NIP-modified spleen cells  (section B).  It is impor- 
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TASLE III 
Effect of Preincubation* of Chemically Modified, Nonradioactive Spleen Cells  With 
C57BL/10 Effector Cells on the Lysis of ChemicaUy  Modified L5MF-22 Tumor Target 
Cells 
Chemical  modification 
of C57BL/10 stimulator  Blocker:target cell 
spleen cells and LSMF-  ratio 
22 target cells 
% Specific  lysis  ±  SE in presence of nonradioactive  C57BL/10 spleen 
cells modified with: 





40:1  34.6 -+ 1.9  31.2 --,. 2.4  37.4 -+ 8.4 
80:1  27.0 -+ 2.8  16.9  ±  2.7  33,1  -+ 1.9 
160:1  21.9 -+ 2.3  12.5 ±  1.4  27.6 ±  1.3 
Not modified  NIP-AGG  NP-AGG  NIP 
20:1  24.3 -+ 2.1  15.1 ±  2.3  26.1  ±  0.2  26.0 -+ 0.6 
40:1  15.7 ±  2.7  4.8 ±  1.3  23.8 _+  L4  24.0 -* 2.0 
80:1  16.6 ±  1.6  9.3 ±  1.4  24.5 -+ 2.1  23.4 ±  1.5 
160:1  15.8  ±  1.2  8.5 +_  1.6  22.2 ±  1.5  20.1  -+ 1.8 
Effector:Target Ratio of section A, 20:1; section B, 40:1. Controls: section A, effector cell lysis of TNPoraedified LSMF-22 targets: 
45.6 ± 2.1%; section B, effector cell lysis of: (a) NIP-AGG-raodified L5MF-22 targets, 27.6 ± 2.9%; (b) NP.AGG-raodified LSMF-22 
targets, 9.5 ±  2.3; (c) NIP modified L5MF-22 targets, (-0.3 -+ 3.6). 
* Inhibitor cells were preineubated for 30 rain at 37°C with the effector cells before addition of s'Cr-labeled target cells. 
experiment, but they were not effective blockers for cytotoxic cells generated by 
sensitization with NIP-AGG-modified cells when assayed on NIP-AGG-modified 
targets (see footnote of Table III). 
Discussion 
The results presented in this report demonstrate that these cytotoxic lym- 
phocytes recognize more than just the dominant terminal feature of the modify- 
ing agent or '~hapten."  In Table I, data are presented showing that cytotoxic 
lymphocytes generated by sensitization of splenic lymphocytes with TNP-modi- 
fled autologous spleen cells lysed H-2-matched, TNP-modified target cells but 
not modified target cells in which the TNP group was separated from the cell 
surface by an alanylglycylglycyl tripeptide spacer. H-2-matched, TNP-AGG- 
modified nonradioactive targets did not inhibit the lysis of  TNP-modified  targets 
by TNP-self-sensitized effector cells (Table III). Such results are compatible with 
previous findings in the chemically modified CML model in which cytotoxic T 
lymphocytes were generated in vitro by sensitization with chemically modified 
autologous cells (10, 11,  13). These findings include the observations that:  (a) 
H-2 homology is required between stimulator and target cells (10, 11,  13); (b) 
TNP-modified and NIP-AGG-modified stimulating cells generate clones of ef- 
fectors which can distinguish between these two modifying agents (11); (c) cold 
target inhibition can occur only when the competing, nonradioactive target cells 
are both H-2-matched and modified with the same agent as the stimulating cells 
(11, 13); and (d) inhibition of the lysis of modified target cells is obtained by 
anti-H-2  sera  directed against  the  modified targets  (16). Furthermore, the 
observations presented in this report are compatible with the results of Janeway 
and co-workers using related nitrophenyl compounds (3, 4) in which specificity 
was  shown  to  include both  the  nitrophenyl groups  and  part  of the  protein 
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It was found in the current  study, however, that effector cells generated by 
sensitization  with TNP-AGG-modified stimulating  cells could lyse TNP-modi- 
fled targets in some but not all experiments  (see lower part of Table I). These 
findings,  which appear to contradict the observation that TNP-AGG-modified 
targets were never lysed by effector cells generated by sensitization with TNP- 
modified autologous stimulating  cells,  might  be accounted for if sensitization 
with TNP-modified cells stimulates only clones of lymphocytes which recognize 
TNP  and  some portion  of autologous H-2  cell surface products.  Sensitization 
with TNP-AGG-modified self would be expected to activate clones of lympho- 
cytes  recognizing  TNP-AGG  and  some  part  of  autologous  H-2  cell  surface 
products. The cross-reactivity with TNP-modified cells could be accounted for by 
either the generation  of a  clone of effector cells which could lyse either TNP- 
AGG-self or TNP-self (cross-reactive clone).  An alternative  possibility is that 
sensitization with TNP-AGG-self could activate two groups of noncross-reacting 
clones: one which recognizes only TNP-AGG-self and a second which recognizes 
only TNP-self. These latter clones could be the same ones which are stimulated 
by TNP-self. 
Effector cells generated by sensitization with NIP-AGG-modified cells consist- 
ently lysed NIP-AGG-modified targets to a greater extent than either NP-AGG- 
or NIP-modified target  cells.  The lower levels of lysis detected by either  NP- 
AGG-  or  NIP-modified  targets  could  also  be  accounted  for  by  at  least  two 
mechanisms.  First, a  clone of effector cells could be generated by sensitization 
with NIP-AGG which could lyse all three targets (cross-reactive clones). Second, 
multiple,  distinct,  noncross-reacting  clones  could be  activated  by NIP-AGG- 
modified stimulating  cells. The latter possibility implies that NIP-AGG-modi- 
fled stimulating  cells can stimulate clones of effector cells unable to lyse NIP- 
AGG-modified target cells. The blocking data shown in section B  of Table III 
support the second possibility. Thus, the population of effector cells generated by 
sensitization  with NIP-AGG-modified stimulating  cells were capable of lysing 
NIP-AGG-modified target cells (27.6%) and to a lesser extent NP-AGG-modified 
target cells (9.5%)  at an effector:target ratio of 40:1  (see footnote of Table III). 
The  clones  of effector  cells  which  lyse  NIP-AGG-modified  target  cells  were 
blocked only by NIP-AGG-modified inhibitor  cells. NP-AGG-modified cells did 
not inhibit this reaction even at a blocker:target ratio of 160:1. This suggests the 
presence  of separate  clones of effector cells,  each of which distinguishes  very 
specifically between NIP-AGG- and NP-AGG-modified target cells even though 
all clones resulted from stimulation by the same modifying agent. Thus, there 
can  be  a  difference  in  discriminating  ability  or  fine  specificity  toward  the 
modifying group for the stimulating and lytic processes. Parallel differences in 
discriminating  power have been frequently observed by Merchant  and Inman 
(unpublished observations) in the case of B-cell activation leading to antibody 
production,  and  subsequent  hapten-directed  hemolytic  lysis  (in  complement- 
dependent plaque assays). The inability of NIP-AGG-sensitized effector cells to 
lyse TNP-AGG-modified target cells demonstrates that AGG is not an exclusive 
immunodeterminant in this reaction. The inability of NP-AGG-modified cells to 
stimulate  effector  cells  demonstrates  the  importance  of the  iodo  group  for 
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The data presented do not support the dual receptor model for T-cell recogni- 
tion in its simplest form. The intimacy or dual receptor model has been proposed 
as a possible expla]  Ltion  for the H-2 requirement for CML in the viral-infected 
(12) and chemically modified systems (13). The hypothesis states that the T-cell 
has two distinct receptors which must be accommodated for cytotoxicity  to occur. 
One receptor is for the simple "hapten" (a hapten as defined in the antibody 
system would be TNP) and the other receptor would involve recognition of  a self- 
H-2 product on the target cell surface. If  this model were valid, one would expect 
to see no example in which an effector cell would distinguish between a hapten 
coupled to a target cell surface and a hapten coupled to a target cell surface with 
a short flexible peptide spacer. For CML responses to TNP-modified autologous 
cells, this two-receptor model in its simplest form should involve the recognition 
of TNP hapten in one receptor and a  self-H-2 cell surface product in the other 
receptor. An effector cell sensitized to TNP-self would be expected to kill equally 
well  TNP-  or  TNP-AGG-modified target  cells,  since  both  would  fulfill  the 
requirements of possessing the hapten TNP and self-H-2 cell surface products. 
In order for the intimacy model to remain viable in the chemically modified 
CML system it is necessary to postulate that the so called hapten involves more 
than just TNP (which is a  hapten for antibody production) and would have to 
include TNP plus one or more adjacent amino acids. 
Summary 
The  specificity of C57BL/10  cytotoxic effector  cells  generated  by  in  vitro 
sensitization  with  autologous spleen  cells  modified with  a  series  of related 
nitrophenyl compounds was investigated. The failure of trinitrophenyl (TNP)° 
sensitized effector cells to lyse TNP-fl-alanylglycylglycyl(AGG)-modified  target 
cells is presented as evidence contradicting the intimacy or dual receptor model 
of T-cell recognition in its simplest form. Data are also shown indicating that 
sensitization  with  N- (3-nitro-4-hydroxy-5-iodophenylacetyl)-AGG-modified 
stimulating cells generates noncross-reacting clones of  cytotoxic effector cells. 
Received for publication 24 June 1976. 
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